Keywords
Parallel imports of pharmaceutical products
Exhaustion of intellectual property rights in the Andean Community
Parallel trade of pharmaceutical products in the European Union
Regulation of parallel imports of pharmaceutical products in Colombia
How to Cite
Abstract
This paper examines the exhaustion of intellectual property rights in the Colombian pharmaceutical sector and the absence of parallel imports of pharmaceutical products in the country. This situation occurs despite the adoption of international exhaustion of rights by the Andean Community and the issuance of Decree 1313 of 2010, which establishes the requirements and procedures to authorize parallel imports of pharmaceutical products and medical devices. For the purpose of offering a comparative analysis, the European experience in the matter is also studied in this work.
References
Barragán, C., Ceballos, M., Marín, D., & Tamayo, Ó. (2012). El agotamiento del derecho a la luz del derecho comunitario. Unión Europea y Comunidad Andina. La Propiedad Inmaterial(16), 225-280. Obtenido de https://revistas.uexternado.edu.co/index.php/propin/article/view/3271/2920
Birg, L. (2018). Parallel Imports and Manufacturer Rebates. Vereins für Socialpolitik 2018: Digitale Wirtschaft - Session: Poster Session Health and Finance, 1(P03). Obtenido de http://hdl.handle.net/10419/181646
Birg, L. (2019). Parallel imports and manufacturer rebates: Evidence from Germany. Discussion Papers(363). Obtenido de http://hdl.handle.net/10419/190943
Bolognini, C. (2008). Thesis presented for the Degree of Master of European Studies. Limiting Parallel Trade of Drugs and Article 82: What Role for Innovation and Efficiencies as Justifications after the ECJ Decision in Sot. Lelos Kai Sia? College of Europe, Bruges Campus, European Legal Studies. Obtenido de https://www.efpia.eu/media/25207/cristian-bolognini-limiting-parallel-trade-of-drugs-and-article-82.pdf
Castro Garcia, J. (2009). El agotamiento de los derechos de propiedad intelectual. La Propiedad Inmaterial(13), 253-282. Retrieved from https://revistas.uexternado.edu.co/index.php/propin/article/view/463/442
Comisión de las Comunidades Europeas. (25 de noviembre de 1998). Comunicación de la Comisión. Relativa al mercado único de los productos farmacéuticos. Obtenido de https://eur-lex.europa.eu/legal-content/ES/TXT/PDF/?uri=CELEX:51998DC0588&from=ES
Consejo Nacional de Política Económica y Social. (2012). Documento CONPES 155. Política Farmacéutica Nacional. Departamento Nacional de Planeación. Obtenido de https://colaboracion.dnp.gov.co/CDT/Conpes/Social/155.pdf
Contreras Jaramillo, J. C. (2015). Origen y sustento del agotamiento de los derechos de propiedad intelectual. Vniversitas(131), 277-322. doi:doi:10.11144/Javeriana.vj131.osad
Contreras Jaramillo, J. C. (2016). Algunos problemas del agotamiento de los derechos de propiedad intelectual respecto de las licencias de software. Vniversitas(132), 111-132. doi:doi:10.11144/Javeriana.vj132.apad
Datosmacro. (2022). Economía y datos de los países 2022. Recuperado el 05 de 07 de 2022, de datosmacro.com: https://datosmacro.expansion.com/paises
García Vidal, Á. (2013). El Comercio Paralelo de Medicamentos. Cuadernos de Derecho Transnacional, 5(2), 315-334. Retrieved from https://e-revistas.uc3m.es/index.php/CDT/article/view/1819/850
Jelovac, I., & Bordoy, C. (2005). Pricing and Welfare Implications of Parallel Imports in the Pharmaceutical Industry. International Journal of Health Care Finance and Economics, 5(1), 5-21. doi:https://www.jstor.org/stable/25067712
Kanavos, P., Costa-i-Font, J., Merkur, S., & Gemmill, M. (2004). The Economic Impact of Pharmaceutical Parallel Trade in European Union Member States: A Stakeholder Analysis. LSE Health and Social Care, London School of Economics and Political Science. Retrieved from https://www.lse.ac.uk/business/consulting/assets/documents/the-economic-impact-of-pharmaceutical-parallel-trade-in-european-union-member-states.pdf
Katz, A. (2016). The economic rationale for exhaustion: distribution and post-sale restrains. En I. Calboli, & E. Lee (Edits.), Research Handbook on Intellectual Property Exhaustion and Parallel Imports (págs. 23-43). EE Elgar. doi:https://doi.org/10.4337/9781783478712
Madrid Berroterán, L. Á., & Corral Ponce, A. (2021). El agotamiento de los derechos de propiedad intelectual en la Comunidad Andina. In H. R. Gómez Apac, J. Baeza, M. G. Rodríguez, J. Chávarro, & P. Solines Moreno, La propiedad industrial y el derecho de autor en Iberoamérica: Tendencias para la tercera década del Siglo XXI (pp. 1057-1116). Universidad Internacional del Ecuador, la Universidad Hemisferios y la Asociación Ecuatoriana de Propiedad Intelectual. Retrieved from https://www.tribunalandino.org.ec/libros/PropiedadIndustrialDerechoAutorIberoamerica.pdf
Maskus, K. E. (2001). Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries. University of Colorado at Boulder. Obtenido de http://www.wipo.int/export/sites/www/about-ip/en/studies/pdf/ssa_maskus_pi.pdf
Meier-Ewert, W. R., & Gutierrez, J. (2022). Intellectual Property and Digital Trade - Mapping International Regulatory Responses to Emerging Issues. En A. Taubman, & J. Watal (Edits.), Trade in Knowledge: Intellectual Property, Trade and Development in a Transformed Global Economy (págs. 108-168). Cambridge University Press. doi:https://doi.org/10.1017/9781108780919.006
Méndez, S. J. (2016). Parallel Trade of Pharmaceuticals: The Danish Market for Statins. Melbourne Institute Working Paper No. 8/16. Melbourne Institute Working Paper Series, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne. Obtenido de https://melbourneinstitute.unimelb.edu.au/downloads/working-paper-series/wp2016n08.pdf
Organización Mundial de la Salud. (2012). Investigación y desarrollo para atender las necesidades sanitarias de los países en desarrollo: fortalecimiento de la financiación y coordinación mundiales. OMS. Obtenido de https://apps.who.int/gb/CEWG/pdf_files/A65_24-sp.pdf
Organización Panamericana de la Salud. (2018). Fondo Estratégico de la OPS - OPS/OMS | Organización Panamericana de la Salud. Recuperado el 2022, de paho.org: https://www.paho.org/hq/index.php?option=com_content&view=article&id=12163%3Apaho-strategic-fund&catid=8775%3Aabout&Itemid=42005&lang=es
Rehmann, W. A. (2009). The European legal foundation for parallel trading. En VAD, 30 Years of Parallel Trade in Pharmaceuticals. Analysis - Facts - Backgrounds (págs. 8-13). German Association of Pharmaceutical Parallel Distributers.
Reichman, J. H., Okediji, R. L., Lianos, I., Jacob, R., & Stothers, C. (2014). The WTO compatibility of a differentiated international exhaustion regime. International Laboratory for Law and Development. Retrieved from http://www.eurasiancommission.org/ru/act/finpol/dobd/intelsobs/Documents/WTO%20Compartibility%20of%20Exhaustion%20Regimes_EEC_SkHSEreport.pdf
Spielberg, P. (abril de 2017). Pharmaceutical Dialogue 57: What are the options for improving access to medicines? Obtenido de VAD News: https://www.vad-news.de/wp-content/uploads/2017/04/pd_57.pdf
United Nations Conference on Trade and Development & International Centre for Trade and Sustainable Development. (2005). Resource Book on TRIPS and Developmnet. Cambridge University Press. doi:https://doi.org/10.1017/CBO9780511511363
Vogler, S., & Martikainen, J. E. (2015). Pharmaceutical Pricing in Europe. In Z.-U.-D. Babar (Ed.), Pharmaceutical Prices in the 21st Century (pp. 243-370). Springer International Publishing Switzerland. doi:10.1007/978-3-319-12169-7_19
Zappalaglio, A. (2016). The Exhaustion of Trade Marks in the PRC compared with the US and EU Experience: A Dilemma that still Needs an Answer. European Intellectual Property Review, 38(10), 610-619. Obtenido de https://www.researchgate.net/publication/308618825_The_exhaustion_of_trademarks_in_the_PRC_compared_with_the_US_and_EU_experience_a_dilemma_that_still_needs_an_answer
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Journal Civilizar: Social and Human Sciences